Drilldown: Medicines
Appearance
Medicines > routes:
oral
& onset
:
1-2 hours
or
30-60 min (sedation); days to weeks (neuroleptic effect) 
& onset
:
1-2 hours
or
30-60 min (sedation); days to weeks (neuroleptic effect) 
Use the filters below to narrow your results.
[[:Category:Antihistamines|Antihistamine]] (1) ·
[[:Category:Antihyperglycemic_agents|Antihyperglycemic agent]] (1) ·
[[:Category:Dibenzothiazepines|Dibenzothiazepine]] (1) ·
[[:Category:H1_receptor_antagonists|Histamine H1 receptor antagonist (second-generation)]] (1) ·
[[:Category:Insulin_secretagogues|Insulin secretagogue]] (1) ·
[[:Category:Neuroleptics|Neuroleptic]] (1) ·
[[:Category:Second-generation neuroleptics|Second-generation (atypical) neuroleptic]] (1) ·
[[:Category:Serotonin-dopamine antagonists|Serotonin-dopamine antagonist]] (1) ·
[[:Category:Sulfonylureas|Sulfonylurea (third-generation)]] (1)
Tablet ~100% relative to oral solution; extensive first-pass metabolism (1) ·
~100% (oral; not significantly affected by food)'"`UNIQ--ref-00000493-QINU`"' (1) ·
~33% (oral; fruit juices including grapefruit, orange, and apple reduce absorption substantially via OATP1A2 inhibition — distinctive interaction not seen with most other H1s)'"`UNIQ--ref-00000CCD-QINU`"' (1)
Avoid; switch to insulin. Neonatal hypoglycemia reported.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Generally considered safe; loratadine and cetirizine have more pregnancy data and are typically preferred.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Pregnancy categories were retired by FDA in 2015. Quetiapine has reassuring active-comparator cohort data without consistent teratogenic signal; among the preferred neuroleptics when treatment is clinically necessary in pregnancy. See pregnancy_details for the full citation set. (1)
Showing below up to 3 results in range #1 to #3.

